Avalyn Pharma’s $175 Million Series C Financing Round

Wilson Sonsini Goodrich & Rosati advised Novo Holdings A/S and Vida Ventures on the transaction.Avalyn Pharma Inc. announced the closing of an oversubscribed $175 million Series…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now